Follow
Lin Lin
Lin Lin
Research Scientist, Duke University
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
Autophagy, cell death, and cancer
L Lin, EH Baehrecke
Molecular & cellular oncology 2 (3), e985913, 2015
2202015
Wild-type p53-induced phosphatase 1 dephosphorylates histone variant γ-H2AX and suppresses DNA double strand break repair
SH Moon, L Lin, X Zhang, TA Nguyen, Y Darlington, AS Waldman, X Lu, ...
Journal of biological chemistry 285 (17), 12935-12947, 2010
1222010
The NF-κB factor relish regulates Atg1 expression and controls autophagy
A Nandy, L Lin, PD Velentzas, LP Wu, EH Baehrecke, N Silverman
Cell reports 25 (8), 2110-2120. e3, 2018
81*2018
Phosphorylation and degradation of MdmX is inhibited by Wip1 phosphatase in the DNA damage response
X Zhang, L Lin, H Guo, J Yang, SN Jones, A Jochemsen, X Lu
Cancer research 69 (20), 7960-7968, 2009
812009
Complement-related regulates autophagy in neighboring cells
L Lin, FSLM Rodrigues, C Kary, A Contet, M Logan, RHG Baxter, W Wood, ...
Cell 170 (1), 158-171. e8, 2017
572017
Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses
M Wang, B Rousseau, K Qiu, G Huang, Y Zhang, H Su, ...
Nature Biotechnology, 1-12, 2023
152023
Development of a mRNA lipid nanoparticle (mRNA-LNP) cancer vaccine to prevent leukemia relapse after stem cell transplant
A Snow, L Lin, SA Hunsucker, Y Wang, R Liu, PM Armistead
Blood 140 (Supplement 1), 7382-7383, 2022
42022
CD3 downregulation identifies high-avidity human CD8 T cells
GT Clutton, AMK Weideman, MA Mischell, S Kallon, SZ Conrad, FR Shaw, ...
Clinical and Experimental Immunology 215 (3), 279-290, 2024
2024
Development of an mRNA Lipid Nanoparticle (mRNA-LNP) Cancer Vaccine to Prevent Leukemia Relapse after Stem Cell Transplant
A Snow, L Lin, S Hunsucker, Y Wang, R Liu, PM Armistead
Transplantation and Cellular Therapy 29 (2), S99, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–9